The Social Impact Fund (SIF) provides loans and equity investments to Australian social enterprises focused on positive social change including improving education, employment and life outcomes for disadvantaged members of the community.

Eye Fund is revolutionising financing of the global eye care industry by making affordable eye care available to people living in poverty. Eye Fund provides loan financing for the development and support of eye care programs, outreach programs and training programs for health care professionals. A collaboration between non-government organisations and private sector institutions, Eye Fund aims to support and/or establish 250 eye care hospitals in developing countries, scaling up the existing eye care industry through introducing debt financing and cross subsidisation of patient fees.

Hireup harnesses the power of technology to revolutionise the way Australians with disability find, hire and manage their own support workers. After producing a minimum viable product, it proved the need and applicability of the model. Hireup then raised $2.5 million via an impact investment in late 2015. The funds raised are helping Hireup to scale quickly and in lockstep with the national rollout of the National Disability Insurance Scheme (NDIS).

Moxidectin, an important new drug for treating river blindness, has been developed for human use with Wyeth/Pfizer. The World Health Organization (WHO) has co-sponsored its development.